Findings can lead to gut replacement therapy in people with intestinal deficiencies
Working with gut stem cells from humans and mice, scientists from the Johns Hopkins Children’s Center and the University of Pittsburgh have successfully grown healthy intestine atop a 3-D scaffold made of a substance used in surgical sutures.
In a further step that takes their work well beyond proof of concept, researchers report their laboratory-created intestine successfully regenerated gut tissue in the colons of dogs with missing gut lining.
The experiments, described ahead of print in the journal Regenerative Medicine, bring researchers closer to creating an implantable intestine as replacement therapy for a range of devastating disorders – including infections, cancer and trauma – that result in loss or death of gut tissue. Chief among them is a condition that affects 12 percent of premature newborns, called necrotizing enterocolitis (NEC), which is marked by the rapid death of intestinal cells and permanent loss of intestinal tissue.
The tube-shaped scaffold, designed several years ago in collaboration with Cornell University researchers and composed of biodegradable material similar to that used in surgical sutures, was a big first step on the quest to develop an implantable replacement intestine. But the new work pushes that effort further because it shows how stem cells, when mixed with immune and connective tissue cells, can grow into normal gut tissue around the scaffold and function inside a living mammal.
Researchers caution that a fully functioning replacement intestine for humans is far off, but they say their results have laid the critical groundwork to do so.
“Our experiments show that the architecture and function of our lab-made intestine strikingly resemble those of the healthy human gut, giving us real hope that our model could be used as the backbone for replacement intestine,” says principal investigator David Hackam, M.D., Ph.D., the Johns Hopkins Children’s Center’s surgeon-in-chief, who initiated and conducted most of the work at the University of Pittsburgh.
In an initial set of experiments reminiscent of a peanut butter-and-jelly sandwich technique, researchers took stem cells from the colons of babies undergoing intestinal surgeries and from mice, then added immune cells called macrophages, the body’s scavengers that seek out and engulf debris along with foreign and diseased cells. To this mix, they added cells called fibroblasts, whose function is to form collagen and other connective substances that bind tissues and organs together. The idea, the scientists say, was to create a mixture that closely mimics the natural composition of the gut.
“Intestinal cells do not grow and develop in a vacuum, so we sought to recreate the richness of the human gut, Hackam says. “We took the PB & J approach, adding a layer of stem cells on top of the scaffold, then topping them with a mixture of immune and collagen cells.”
Adding these components, they report, enhanced the growth of intestinal stem cells and differentiation into various mature cell types critical to the function of a healthy intestine. In comparison, stem cells grown in isolation without immune and connective cells in the mix grew more slowly and failed to differentiate well into multiple cell types.
In another set of experiments, researchers added probiotic bacteria to the newly created intestinal tissue. Doing so further amplified the growth and differentiation of new gut cells, specifically the growth of Paneth cells responsible for production of infection-fighting proteins that guard against intestinal infections, Hackam says, a finding that highlights the therapeutic potential of certain probiotics for NEC. Next, the team added bacteria-laden stool cells obtained from infants with NEC, but they observed a dramatic decrease in the number of intestinal cells called goblet cells, which are responsible for the production of protective mucus that coats and shields the intestine – a common occurrence in NEC. The observation, Hackam says, supports the notion that certain gut bacteria present in the colons of babies with NEC are responsible for sparking the rapid death of gut tissue that occurs in the condition.
Next, researchers implanted the newly created intestine into the bellies of mice. In a matter of days, the implanted intestine began producing new intestinal stem cells and stimulated the growth of new blood vessels around the implant. That observation, researchers say, affirmed the ability of the 3-D intestine to spur the growth of new tissue not only in lab dishes, but also in living organisms.
In a final step, the investigators implanted pieces of the newly created intestine – about 1.6 inches in length – into the lower portion of dog colons lacking parts of their intestinal lining. For two months, the dogs underwent periodic colonoscopies and intestinal biopsies. Strikingly, the guts of dogs with implanted intestines healed completely within eight weeks. By contrast, dogs that didn’t get intestinal implants experienced continued inflammation and scarring of their guts.
Read more: Lab-Grown 3-D Intestine Regenerates Gut Lining in Dogs
The Latest on: Regenerative medicine
[google_news title=”” keyword=”Regenerative medicine” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Regenerative medicine
- Winston-Salem regenerative medicine company ProKidney reports Q4 loss as R&D, personnel costs increaseon March 31, 2023 at 12:07 pm
ProKidney (Nasdaq: PROK), a regenerative medicine company from Winston-Salem, reported increases in cash on hand and research and development expenses as it advances clinical trials of its lead ...
- Improving Arthritis Care and Joint Pain Treatment with South Bend Regenerative Medicine from QC Kinetix (Mishawaka)on March 31, 2023 at 9:41 am
QC Kinetix (Mishawaka) is a regenerative medicine clinic providing natural treatment therapies to patients suffering from joint pain. Its treatment approach leverages the body's natural abilities to ...
- Regenerative Medicine For Cartilage Global Market Report 2023on March 31, 2023 at 6:07 am
Major players in the regenerative medicine for cartilage market are B. Braun Melsungen AG, Zimmer Biomet Holdings Inc., Vericel Corporation, Stryker Corporation, Smith & Nephew plc, Arthrex Inc., ...
- Dr. Steven Cohen Continues to Craft New Futures in Aesthetic Medicineon March 31, 2023 at 5:08 am
Most cosmetic surgeons are practitioners of youth preservation and image pragmatics. Dr. Steven Cohen has always stepped it up a notch – or ten – ... Read More ...
- Peptide-Based Inks for 3D Printing May Boost Regenerative Medicineon March 30, 2023 at 11:46 am
Hydrogel could be used for 3D printing structures that can grow active cells for transplant within living beings.
- New RNA-based toolkit to regulate gene activity could advance regenerative medicine, gene therapy and biotechnologyon March 30, 2023 at 6:24 am
The Okinawa Institute of Science and Technology (OIST), in collaboration with Astellas Pharma Inc., has developed a new toolkit that uses small molecules to control the activity of a piece of ...
- Regenerative medicine to undergo trialson March 29, 2023 at 5:00 pm
Minister of Health and Welfare Hsueh Jui-yuan (薛瑞元) yesterday dismissed concerns that a bill on regenerative medicine would turn people into “laboratory mice,” saying that such therapies would still ...
- Heart attack study could change the game in regenerative medicineon March 29, 2023 at 2:07 pm
Sanford Burnham Prebys researchers have identified a group of proteins that could be the secret to cellular reprogramming, an emerging approach in regenerative medicine in which scientists transform ...
- Global Regenerative Medicine Market 2023 [Latest Report] | Driving Growth Through an Economic Downturn by 2030on March 29, 2023 at 2:50 am
"Our latest research report highlights the dynamic growth of the global Regenerative Medicine market and provides comprehensive insights into the market size, share, and revenue projections for the ...
- ISSCA Announces Upcoming Conference On Regenerative Medicine And Cellular Therapies In Buenos Aireson March 29, 2023 at 2:01 am
Conference on Regenerative Medicine and Cellular Therapies in Buenos Aires, Argentina. The conference is scheduled at the Marriott Hotel on June 3-4, 2023. This spectacular event offers scientists and ...
via Bing News